Significant Pharmaceuticals Reported in US Patents

• Author : Thomas F. DeRosa
• Publisher : Elsevier
• Release : 07 July 2010

Significant Pharmaceuticals Reported in US Patents identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation,

• Author : Thomas F. DeRosa
• Publisher : Elsevier
• Release : 21 March 2006

Advances in Synthetic Organic Chemistry and Methods Reported in US Patents provides synthetic guidelines for preparing current and commercially significant organic compounds, derivatives, and intermediates as reported in issued US Patents. Industries surveyed include agrochemical, cosmetics and personal care products. Each entry contains extensive information such as explicit laboratory directions for preparing all chemical intermediates and characterization data. Furthermore, product optimization studies, industrial preparation, and new synthetic methods have been included for selected entries, as well as projected research directions

• Author : Thomas F. DeRosa
• Publisher : Elsevier
• Release : 11 October 2012

The objective is writing ‘Next Generation Chemical Additives’ to identify the next generation chemical additives for eight selected industries. The text will also provide methods for their preparation, additive treatment levels, and testing methods to evaluate additive performance. To ensure optimum performance of materials and products, chemists, formulators, and blenders must be provided with the most current information on existing chemical additives. It is even more essential that corporate operations officers can easily identify the next generation of chemical additives.

• Author : Thomas F. DeRosa
• Publisher : John Wiley & Sons
• Release : 16 September 2008

The objective of this book is to convey to academic and industrial researchers and students advances in synthetic and characterization methods in 9 selected areas of polymer chemistry reported in 2007-2008 US Patents. It reviews the impact of newer bulk anionic, cationic, and free radical polymerization methods within selected industrial applications. Bulk and surface crosslinking agents using selected bi- and tri-functional reagents, photochemical methods, or free radical agents are also reviewed. Finally, there is a separate section on cationic and cationic

• Author : Anonim
• Publisher : Unknown
• Release : 07 June 1981

• Author : Harold C. Wegner
• Publisher : Springer
• Release : 23 March 1992

A practical guide to patent prosecution and strategy in the US with particular reference to invention in chemicals and biotechnology. The presentation is focused on case law in the US and deals with specific cases. A section is devoted to international patent protection.

• Author : Amalia Athanasiadou
• Publisher : Kluwer Law International B.V.
• Release : 14 August 2018

Reverse payment settlements or “pay-for-delay agreements” between originators and generic drug manufacturers create heated debates regarding the balance between competition and intellectual property law. These settlements touch upon sensitive issues such as timely generic entry and access to affordable pharmaceuticals and also the need to preserve innovation incentives for originators and to strengthen the pipeline of life-saving pharmaceuticals. This book is one of the first to critically and comparatively analyse how such patent settlements and various other strategies employed by

• Author : Julio J. Nogués
• Publisher : World Bank Publications
• Release : 07 June 1990

• Author : Sherry S. Marcellin
• Publisher : Routledge
• Release : 24 February 2016

This book provides a fresh, multidisciplinary, and exciting look at the making and remaking of pharmaceutical patents at the GATT/WTO, by utilising a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin focuses on the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement and consequently, the role of the African Group at the WTO in the remaking of those patent provisions.

• Author : Josef Drexl,Nari Lee
• Publisher : Edward Elgar Publishing
• Release : 01 January 2013

Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book,

• Author : John R. Thomas
• Publisher : Bna Books
• Release : 07 June 2023

"Appendix" is included in the CD-ROM.

• Author : Henry G. Grabowski,John Mitcham Vernon
• Publisher : A E I Press
• Release : 07 June 1983

• Author : Martin A. Voet
• Publisher : BrownWalker Press
• Release : 01 May 2020

This Sixth Edition of The Generic Challenge provides important new updates on current regulatory, legal and commercial issues affecting brand and generic pharmaceutical products, including new laws establishing generics for biologics, and changes brought about by the recently enacted America Invents Act. It explains clearly and understandably the roles of patents, FDA regulation of drugs and the Hatch Waxman Act in commercial drug development in light of generic challenges and how improvements in innovative drug products provide benefits to patients

• Author : Burcu Kiliç
• Publisher : Edward Elgar Publishing
• Release : 31 July 2014

Boosting Pharmaceutical Innovation In The Post-TRIPS Era investigates the concept of innovation and illustrates the crucial role that patent strategies play within processes of pharmaceutical innovation. Drawing on extensive country and company case studies, it identifies the key issues relevant to the revival of local pharmaceutical industries.

• Author : Anonim
• Publisher : Unknown
• Release : 07 June 2023